Differential retention of adalimumab and etanercept biosimilars compared to originator treatments: Results of a retrospective French multicenter study

Overview of attention for article published in Frontiers in Medicine, October 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (62nd percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 12 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 5,549 followers.

Estudio multicéntrico retrospectivo compara la retención del tratamiento de bDMARDs (etanercept y adalimumab) original y #biosimilar en pacientes reumatológicos en Francia y concluye que la continuación es mayor con #biosimilar que con original. https://t.

02 Nov 2022

Reply Repost Favourite

RT @VincentGoeb: Differential retention of adalimumab and etanercept biosimilars compared to originator treatments: Results of a retrospect…

11 Oct 2022

Reply Repost Favourite

Differential retention of adalimumab and etanercept biosimilars compared to originator treatments: Results of a retrospective French multicenter study https://t.co/897FQfS8cs

06 Oct 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.